NOVARTIS INC 13D and 13G filings for CELLULAR BIOMEDICINE GROUP, IN:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-23 7:57 pm Sale |
2021-02-19 | 13D | CELLULAR BIOMEDICINE GROUP, IN CBMG |
NOVARTIS INC | 0 0.000% |
-1,458,257 (Position Closed) |
Filing |
| 2020-08-14 4:32 pm Unchanged |
2020-08-11 | 13D | CELLULAR BIOMEDICINE GROUP, IN CBMG |
NOVARTIS INC | 1,458,257 7.500% |
0 (Unchanged) |
Filing |